P2Et |
|
Vaxjo ID |
303 |
|
Vaccine Adjuvant Name |
P2Et |
|
Adjuvant VO ID |
VO_0005270
|
|
Description |
A gallotannin-rich fraction from Caesalpinia spinosa. |
|
Stage of Development |
Research |
|
Host Species for Testing |
Rat |
|
Components |
gallotannin-rich fraction from Caesalpinia spinosa |
|
Structure |
Described as a "gallotannin-rich fraction"; specific molecular structure not provided. |
|
Preparation |
It is a fraction from Caesalpinia spinosa; detailed preparation steps are not described in the abstract. |
|
Function |
The present work evaluates IR induction after treatment with a gallotannin-rich fraction from Caesalpinia spinosa (P2Et) |
|
Safety |
Natural compounds, in general, are mentioned as having "low toxicity". Specific safety data for P2Et is not detailed in the abstract. |
| Related Vaccine(s) |
|
| References |
Urueña et al., 2015: Urueña C, Gomez A, Sandoval T, Hernandez J, Li S, Barreto A, Fiorentino S. Multifunctional T Lymphocytes Generated After Therapy With an Antitumor Gallotanin-Rich Normalized Fraction Are Related to Primary Tumor Size Reduction in a Breast Cancer Model. Integrative cancer therapies. 2015; 14(5); 468-483. [PubMed: 26220604].
|
